An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Clinical Trial ID NCT00528528

PubWeight™ 3.21‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00528528

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. Gut 2012 1.63
2 Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples. Virol J 2013 0.83
3 Telaprevir. Drugs R D 2010 0.75
Next 100